XML 86 R32.htm IDEA: XBRL DOCUMENT v3.20.1
INCOME TAXES (Tables)
12 Months Ended
Jan. 31, 2020
INCOME TAXES  
Schedule of components of company's income tax benefit (expense)

 

 

 

 

 

 

 

 

 

 

 

 

    

2020

    

2019

    

2018

Current:

 

 

 

 

 

 

 

 

 

Federal

 

$

77

 

$

3,603

 

$

(32,490)

State

 

 

336

 

 

(1,091)

 

 

(7,853)

 

 

 

413

 

 

2,512

 

 

(40,343)

Deferred:

 

 

 

 

 

 

 

 

 

Federal

 

 

6,825

 

 

971

 

 

 2

State

 

 

(185)

 

 

1,168

 

 

62

 

 

 

6,640

 

 

2,139

 

 

64

Income tax  benefit (expense)

 

$

7,053

 

$

4,651

 

$

(40,279)

 

Schedule of actual income tax expense amounts

 

 

 

 

 

 

 

 

 

 

 

 

    

2020

    

2019

    

2018

Computed expected income tax benefit (expense)

 

$

 10,030

 

$

(9,916)

 

$

(38,078)

Difference resulting from:

 

 

 

 

 

 

 

 

 

State income taxes, net of federal tax effect

 

 

 81

 

 

 683

 

 

(5,042)

Elimination of net operating loss benefit

 

 

(7,239)

 

 

 —

 

 

 —

Utilization of net operating loss carryforward

 

 

 —

 

 

 1,730

 

 

 —

Bad debt loss

 

 

 6,205

 

 

 —

 

 

 —

Foreign tax rate differential

 

 

(722)

 

 

 86

 

 

(301)

Goodwill impairment losses

 

 

(763)

 

 

(266)

 

 

(168)

Stock options

 

 

 210

 

 

 32

 

 

 962

Domestic production activities deduction

 

 

 —

 

 

 —

 

 

 3,204

Other permanent differences, net

 

 

(599)

 

 

(1,319)

 

 

(973)

Federal research and development tax credits

 

 

 —

 

 

 13,866

 

 

Adjustments and other differences

 

 

(150)

 

 

(245)

 

 

 117

Income tax benefit (expense)

 

$

 7,053

 

$

 4,651

 

$

(40,279)

 

Schedule of tax effects of temporary differences that gave rise to deferred tax assets and liabilities

 

 

 

 

 

 

 

 

 

    

2020

    

2019

Assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

22,683

 

$

8,228

Stock awards

 

 

2,367

 

 

2,188

Research and development credit carryforwards

 

 

134

 

 

631

Purchased intangibles

 

 

415

 

 

604

Accrued expenses and other

 

 

994

 

 

758

 

 

 

26,593

 

 

12,409

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

Purchased intangibles

 

 

(3,317)

 

 

(3,373)

Construction contracts

 

 

(1,618)

 

 

(454)

Property and equipment

 

 

(1,983)

 

 

(1,986)

Other

 

 

(193)

 

 

(145)

 

 

 

(7,111)

 

 

(5,958)

Valuation Allowances

 

 

(11,588)

 

 

(5,194)

Deferred tax assets

 

$

7,894

 

$

1,257